Carcinogenesis, Vol 18, 503-509, Copyright © 1997 by Oxford University Press
LA Mooney, DA Bell, RM Santella, AM Van Bennekum, R Ottman, M Paik, WS Blaner, GW Lucier, L Covey, TL Young, TB Cooper, AH Glassman and FP Perera
Prior epidemiological evidence suggests that genes controlling the
metabolism of carcinogens and antioxidant/nutritional status are associated
with lung cancer risk, possibly through their ability to modulate DNA
damage by carcinogens. We performed a cross-sectional analysis of 159 heavy
smokers from a cohort of subjects enrolled in a smoking cessation program.
A total of 159 blood samples were analyzed to determine the relative
contributions of genetic polymorphisms [CYP1A1 MspI and exon 7 and
glutathione S-transferase M1 (GSTM1)] and plasma micronutrients to
polycyclic aromatic hydrocarbon-DNA (PAH-DNA) adduct levels. DNA damage in
smokers was affected by genetic polymorphisms and nutritional status.
Smokers with the CYP1A1 exon 7 valine polymorphism had significantly higher
(2-fold, P < or = 0.03) levels of DNA damage than those without. In
parallel models, PAH-DNA adducts were inversely associated with plasma
levels of retinol (beta = -0.93, P = 0.01), beta-carotene (beta = -0.18, P
= 0.09), and alpha- tocopherol (beta = -0.28, P = 0.21) in 159 subjects.
The association between smoking-adjusted plasma beta-carotene levels and
DNA damage was only significant in those subjects lacking the GSTM1
detoxification gene (beta = -0.30, P = 0.05, n = 75). There was a
statistical interaction between beta-carotene and alpha-tocopherol; when
beta- carotene was low, alpha-tocopherol had a significant protective
effect (beta = -0.78, P = 0.04) on adducts, but not when beta-carotene was
high (beta = -0.16, P = 0.57). Plasma alpha-tocopherol was significantly
correlated with beta-carotene (r = 0.36, P = 0.0005) and less strongly with
retinol (r = 0.20, P = 0.0005). These results suggest that several
micronutrients may act in concert to protect against DNA damage and
highlight the importance of assessing overall antioxidant status. In
conclusion, a subset of smokers may be at increased risk of DNA damage and
possibly lung cancer due to the combined effect of low plasma
micronutrients and genetic susceptibility factors. The use of biological
markers to assess efficacy of interventions and to study mechanisms of
micronutrients is timely given the current debate regarding the use of
chemopreventive agents in high risk populations.
ARTICLES
Contribution of genetic and nutritional factors to DNA damage in heavy smokers
Columbia University School of Public Health, Division of Environmental Health Sciences, New York, NY 10032, USA.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E. A. Kelvin, S. Edwards, W. Jedrychowski, R. L. Schleicher, D. Camann, D. Tang, and F. P. Perera Modulation of the Effect of Prenatal PAH Exposure on PAH-DNA Adducts in Cord Blood by Plasma Antioxidants Cancer Epidemiol. Biomarkers Prev., August 1, 2009; 18(8): 2262 - 2268. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Veglia, S. Loft, G. Matullo, M. Peluso, A. Munnia, F. Perera, D. H. Phillips, D. Tang, H. Autrup, O. Raaschou-Nielsen, et al. DNA adducts and cancer risk in prospective studies: a pooled analysis and a meta-analysis Carcinogenesis, May 1, 2008; 29(5): 932 - 936. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Crew, M. D. Gammon, M. B. Terry, F. F. Zhang, L. B. Zablotska, M. Agrawal, J. Shen, C.-M. Long, S. M. Eng, S. K. Sagiv, et al. Polymorphisms in Nucleotide Excision Repair Genes, Polycyclic Aromatic Hydrocarbon-DNA Adducts, and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2033 - 2041. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Wilms, A. W. Boots, V. C.J. de Boer, L. M. Maas, D. M.F.A. Pachen, R. W.H. Gottschalk, H. B. Ketelslegers, R. W.L. Godschalk, G. R.M.M. Haenen, F. J. van Schooten, et al. Impact of multiple genetic polymorphisms on effects of a 4-week blueberry juice intervention on ex vivo induced lymphocytic DNA damage in human volunteers Carcinogenesis, August 1, 2007; 28(8): 1800 - 1806. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Hecht, S. G. Carmella, A. Yoder, M. Chen, Z.-z. Li, C. Le, R. Dayton, J. Jensen, and D. K. Hatsukami Comparison of polymorphisms in genes involved in polycyclic aromatic hydrocarbon metabolism with urinary phenanthrene metabolite ratios in smokers. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1805 - 1811. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Peluso, A. Munnia, G. Hoek, M. Krzyzanowski, F. Veglia, L. Airoldi, H. Autrup, A. Dunning, S. Garte, P. Hainaut, et al. DNA Adducts and Lung Cancer Risk: A Prospective Study Cancer Res., September 1, 2005; 65(17): 8042 - 8048. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hou, N. Chatterjee, W.-Y. Huang, A. Baccarelli, S. Yadavalli, M. Yeager, R. S. Bresalier, S. J. Chanock, N. E. Caporaso, B.-T. Ji, et al. CYP1A1 Val462 and NQO1 Ser187 polymorphisms, cigarette use, and risk for colorectal adenoma Carcinogenesis, June 1, 2005; 26(6): 1122 - 1128. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. Masson, L. Sharp, S. C. Cotton, and J. Little Cytochrome P-450 1A1 Gene Polymorphisms and Risk of Breast Cancer: A HuGE Review Am. J. Epidemiol., May 15, 2005; 161(10): 901 - 915. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Mooney, A. M. Madsen, D. Tang, M. A. Orjuela, W.-Y. Tsai, E. R. Garduno, and F. P. Perera Antioxidant Vitamin Supplementation Reduces Benzo(a)pyrene-DNA Adducts and Potential Cancer Risk in Female Smokers Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 237 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Peluso, M. Neri, G. Margarino, C. Mereu, A. Munnia, M. Ceppi, M. Buratti, R. Felletti, F. Stea, R. Quaglia, et al. Comparison of DNA adduct levels in nasal mucosa, lymphocytes and bronchial mucosa of cigarette smokers and interaction with metabolic gene polymorphisms Carcinogenesis, December 1, 2004; 25(12): 2459 - 2465. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. S. Kleinjans, M. H. M. van Herwijnen, J. M. S. van Maanen, L. M. Maas, T. M. C. M. de Kok, H. J. J. Moonen, and J. J. Briede In vitro investigations into the interaction of {beta}-carotene with DNA: evidence for the role of carbon-centered free radicals Carcinogenesis, July 1, 2004; 25(7): 1249 - 1256. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Palli, G. Masala, M. Peluso, L. Gaspari, V. Krogh, A. Munnia, S. Panico, C. Saieva, R. Tumino, P. Vineis, et al. The effects of diet on DNA bulky adduct levels are strongly modified by GSTM1 genotype: a study on 634 subjects Carcinogenesis, April 1, 2004; 25(4): 577 - 584. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hashibe, P. Brennan, R. C. Strange, R. Bhisey, I. Cascorbi, P. Lazarus, M. B. O. Ophuis, S. Benhamou, W. D. Foulkes, T. Katoh, et al. Meta- and Pooled Analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 Genotypes and Risk of Head and Neck Cancer Cancer Epidemiol. Biomarkers Prev., December 1, 2003; 12(12): 1509 - 1517. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Palli, G. Masala, P. Vineis, S. Garte, C. Saieva, V. Krogh, S. Panico, R. Tumino, A. Munnia, E. Riboli, et al. Biomarkers of dietary intake of micronutrients modulate DNA adduct levels in healthy adults Carcinogenesis, April 1, 2003; 24(4): 739 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Veglia, G. Matullo, and P. Vineis Bulky DNA Adducts and Risk of Cancer: A Meta-Analysis Cancer Epidemiol. Biomarkers Prev., February 1, 2003; 12(2): 157 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Phillips Smoking-related DNA and protein adducts in human tissues Carcinogenesis, December 1, 2002; 23(12): 1979 - 2004. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.K. Field and J.H. Youngson The Liverpool Lung Project: a molecular epidemiological study of early lung cancer detection Eur. Respir. J., August 1, 2002; 20(2): 464 - 479. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Firozi, M. L. Bondy, A. A. Sahin, P. Chang, F. Lukmanji, E. S. Singletary, M. M. Hassan, and D. Li Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer Carcinogenesis, February 1, 2002; 23(2): 301 - 306. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Zhang, M Ichiba, K Hara, S Zhang, T Hanaoka, G Pan, Y Yamano, K Takahashi, and K Tomokuni Urinary 1-hydroxypyrene in coke oven workers relative to exposure, alcohol consumption, and metabolic enzymes Occup. Environ. Med., November 1, 2001; 58(11): 716 - 721. [Abstract] [Full Text] |
||||
![]() |
D. Tang, D. H. Phillips, M. Stampfer, L. A. Mooney, Y. Hsu, S. Cho, W.-Y. Tsai, J. Ma, K. J. Cole, M. N. She, et al. Association between Carcinogen-DNA Adducts in White Blood Cells and Lung Cancer Risk in the Physicians Health Study Cancer Res., September 1, 2001; 61(18): 6708 - 6712. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B. J. Smith, P. A. Harper, J. M. Y. Wong, M. S. M. Lam, K. R. Reid, D. Petsikas, and T. E. Massey Human Lung Microsomal Cytochrome P4501A1 (CYP1A1) Activities: Impact of Smoking Status and CYP1A1, Aryl Hydrocarbon Receptor, and Glutathione S-Transferase M1 Genetic Polymorphisms Cancer Epidemiol. Biomarkers Prev., August 1, 2001; 10(8): 839 - 853. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Mooney, F. P. Perera, A. M. Van Bennekum, W. S. Blaner, J. Karkoszka, L. Covey, Y. Hsu, T. B. Cooper, and K. Frenkel Gender Differences in Autoantibodies to Oxidative DNA Base Damage in Cigarette Smokers Cancer Epidemiol. Biomarkers Prev., June 1, 2001; 10(6): 641 - 648. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. IZZOTTI, C. CARTIGLIA, J. LEWTAS, and S. DE FLORA Increased DNA alterations in atherosclerotic lesions of individuals lacking the GSTM1 genotype FASEB J, March 1, 2001; 15(3): 752 - 757. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Song, W. Tan, D. Xing, and D. Lin CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China Carcinogenesis, January 1, 2001; 22(1): 11 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Jacobson, M. D. Begg, L. W. Wang, Q. Wang, M. Agarwal, E. Norkus, V. N. Singh, T.-L. Young, D. Yang, and R. M. Santella Effects of a 6-Month Vitamin Intervention on DNA Damage in Heavy Smokers Cancer Epidemiol. Biomarkers Prev., December 1, 2000; 9(12): 1303 - 1311. [Abstract] [Full Text] |
||||
![]() |
Qingyi Wei, Lie Cheng, C. I. Amos, L.-E. Wang, Zhaozheng Guo, W. K. Hong, and M. R. Spitz Repair of Tobacco Carcinogen-Induced DNA Adducts and Lung Cancer Risk: a Molecular Epidemiologic Study J Natl Cancer Inst, November 1, 2000; 92(21): 1764 - 1772. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. V. Nerurkar, L. Okinaka, C. Aoki, A. Seifried, A. Lum-Jones, L. R. Wilkens, and L. Le Marchand CYP1A1, GSTM1, and GSTP1 Genetic Polymorphisms and Urinary 1-Hydroxypyrene Excretion in Non-Occupationally Exposed Individuals Cancer Epidemiol. Biomarkers Prev., October 1, 2000; 9(10): 1119 - 1122. [Abstract] [Full Text] |
||||
![]() |
F. P. Perera Molecular Epidemiology: On the Path to Prevention? J Natl Cancer Inst, April 19, 2000; 92(8): 602 - 612. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. P. Perera and I.B. Weinstein Molecular epidemiology: recent advances and future directions Carcinogenesis, March 1, 2000; 21(3): 517 - 524. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Whyatt, F. P. Perera, W. Jedrychowski, R. M. Santella, S. Garte, and D. A. Bell Association between Polycyclic Aromatic Hydrocarbon-DNA Adduct Levels in Maternal and Newborn White Blood Cells and Glutathione S-Transferase P1 and CYP1A1 Polymorphisms Cancer Epidemiol. Biomarkers Prev., February 1, 2000; 9(2): 207 - 212. [Abstract] [Full Text] |
||||
![]() |
H. Bartsch, U. Nair, A. Risch, M. Rojas, H. Wikman, and K. Alexandrov Genetic Polymorphism of CYP Genes, Alone or in Combination, as a Risk Modifier of Tobacco-related Cancers Cancer Epidemiol. Biomarkers Prev., January 1, 2000; 9(1): 3 - 28. [Abstract] [Full Text] |
||||
![]() |
M. Rojas, I. Cascorbi, K. Alexandrov, E. Kriek, G. Auburtin, L. Mayer, A. Kopp-Schneider, I. Roots, and H. Bartsch Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism Carcinogenesis, January 1, 2000; 21(1): 35 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Woodson, C. Stewart, M. Barrett, N. K. Bhat, J. Virtamo, P. R. Taylor, and D. Albanes Effect of Vitamin Intervention on the Relationship between GSTM1, Smoking, and Lung Cancer Risk Among Male Smokers Cancer Epidemiol. Biomarkers Prev., November 1, 1999; 8(11): 965 - 970. [Abstract] [Full Text] |
||||
![]() |
F. P. Perera Environment and Cancer: Who Are Susceptible? Science, November 7, 1997; 278(5340): 1068 - 1073. [Abstract] [Full Text] |
||||








